A protein found in brown fat, but not typical white fat, is key to how the energy-burning brown fat cells function
While most fat cells in the human body store energy, everyone has a small subset of brown fat cells that do the opposite—burn energy and generate heat. Now, Salk researchers have discovered how the molecule ERR? gives this “healthier” brown fat its energy-expending identity, making those cells ready to warm you up when you step into the cold, and potentially offering a new therapeutic target for diseases related to obesity. The paper appears in Cell Reports on March 13, 2018.
“This not only advances our understanding of how the body responds to cold, but could lead to new ways to control the amount of brown fat in the body, which has links to obesity, diabetes and fatty liver disease,” says senior author Ronald Evans, Howard Hughes Medical Institute investigator and holder of Salk’s March of Dimes Chair in Molecular and Developmental Biology.
Until about a decade ago, scientists thought that only babies—who can’t yet shiver to warm up—had brown fat in their bodies. Studies have since shown that adults also have brown fat, albeit at much lower levels, and people with lower body mass indexes (BMIs) tend to have more of it. At a cellular level, brown fat cells are crammed full of energy-generating mitochondria, which give the cells their brown color.
In the new work, Evans’ group focused on estrogen-related receptor gamma (ERR?), a gene that is active at high levels in brown fat cells.
“We were interested in what maintains brown fat, even when we’re not exposed to cold all the time,” says Maryam Ahmadian, a Salk research associate and first author of the new paper.
The team found that brown fat cells express the ERR? gene all the time (not just in response to cold) and that white fat cells do not express the gene at all. And by studying mice lacking the gene for ERR? (and therefore unable to make the ERRy molecule), the team observed that all brown fat cells resembled white cells in these mice. Additionally, the animals were unable to maintain their body temperature when exposed to cold temperatures. While 80 percent of normal mice are able to handle a temperature drop, all mice lacking ERR? did not tolerate the cold. However, there was no difference in the metabolism or weight of the mice. Together, the experiments reveal that ERR? is key to helping brown fat maintain its identity and its ability to respond to cold.
Since the ERR? gene codes for a protein that can travel into the cell nucleus and directly control the expression of other genes, the team also probed which genes were mediated by ERR? in brown fat cells. They pinpointed a number of genes already known to be important in brown fat, but which hadn’t been specifically linked to ERR? inthe past.
“We uncovered the factors that are both involved in protection against the cold and underpin brown fat identity,” says Michael Downes, a Salk senior scientist and co–senior author of the paper.
The group is planning future studies that look at the effect of activating ERR? in white fat cells—which they suspect could make some white fat resemble brown fat, and potentially help treat obesity and diabetes. They also want to study whether the role of ERR? in the brown fat of humans is the same as what they’ve observed in mice.
Learn more: Molecule that gives energy-burning brown fat its identity could lead to drugs for obesity
The Latest on: Drug for obesity
[google_news title=”” keyword=”drug for obesity” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Drug for obesity
- Korean drug makers flock to obesity treatmenton May 8, 2024 at 12:51 am
South Korea’s pharmaceutical companies are accelerating the development of anti-obesity drugs to take share in the rapidly growing market, which is estimated to hit $100 billion by 2030. Hanmi ...
- Ozempic babies: A surprise side effect of weight loss drugson May 7, 2024 at 11:00 pm
Women taking Ozempic or similar drugs for diabetes or weight loss are taking to social media to commiserate about an unexpected side effect — "surprise pregnancies," said The Washington Post. There is ...
- Study Shows Endoscopic Sleeve Gastroplasty Outperforms Trendy Weight-Loss Drugson May 7, 2024 at 2:39 pm
A study suggests endoscopic sleeve gastroplasty is a more cost-effective obesity treatment than new diet drugs.
- States consider whether to add coverage for some obesity medicineson May 7, 2024 at 2:21 pm
Medicaid is required to cover almost all drugs, but Congress specifically excluded those for weight loss. Even so, 16 states now cover Wegovy. Others are considering it, but it could strain budgets.
- A Year on Ozempic Taught Me We’re Thinking About Obesity All Wrongon May 6, 2024 at 10:03 pm
This is happening because we are trapped in a set of old stories about what obesity is and the morally acceptable ways to overcome it. But the fact that so many of us are turning to the new ...
- A New Way To Treat Obesity? Scientists Discover Surprising Effects of New Drugon May 5, 2024 at 3:06 am
Researchers at Karolinska Institute have potentially discovered a novel method to combat obesity and associated conditions by focusing on the mitochondria, the powerhouses of the cell. A study publish ...
- Amgen’s obesity drug puts stock on pace for best day since 2009 as analysts predict big gains to comeon May 3, 2024 at 7:09 am
Fueled by upbeat management comments on an experimental obesity treatment, Amgen’s stock jumped more than 12% early Friday — and analysts see more gains ahead as the company maps out late-stage trials ...
- New drug candidate reverses obesity in mice by transforming liver metabolismon May 1, 2024 at 10:11 pm
A mitochondrial transcription inhibitor (IMT) shifted metabolism in high-fat diet mice toward fatty acid oxidation, leading to weight loss, reduced liver fat, and improved glucose tolerance.
- Listen: Controversial brain tissue research, obesity drug sales, and Novartis’ M&A dramaon May 1, 2024 at 5:00 pm
Also on this week’s episode, we discuss Novartis’ effort to acquire MorphoSys, and the latest news on Eli Lilly and Novo Nordisk’s blockbuster obesity drugs with Elaine Chen, the newest member of STAT ...
via Bing News